Article

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

2020-06-28

Abstract excerpt

Convalescent plasma is currently one of the leading treatments for COVID-19, but there is a paucity of data identifying therapeutic efficacy. A comprehensive analysis of the antibody responses in potential plasma donors and an understanding of the clinical and demographic factors that drive variant antibody responses is needed. Among 126 potential convalescent plasma donors, the humoral immune response was evaluat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b4ebfb85-433a-5d93-84b1-09970e5c8a6a
DOI: 10.1101/2020.06.26.20139063

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationDOI 10.1101/2020.06.26.20139063Read

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read

Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralizationSemantic proximity Read

Decline of humoral responses against SARS-CoV-2 Spike in convalescent individualsSemantic proximity Read

Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 <i>In Vitro</i> Virus Neutralization in Convalescent PlasmaSemantic proximity Read

Functional Antibodies in COVID-19 Convalescent PlasmaSemantic proximity Read

A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma TherapySemantic proximity Read

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasmaSemantic proximity Read

High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samplesSemantic proximity Read

Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)Semantic proximity Read

Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agentsSemantic proximity Read

Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in ArgentinaSemantic proximity Read

Dynamics of SARS-CoV-2-specific antibodies during and after COVID19: Lessons from a biobank in ArgentinaSemantic proximity Read